NEW YORK, March 27, 2026 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Zynex, Inc. (OTC PINK: ZYXIQ). Shareholders who purchased shares of ZYXIQ during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/zynex-inc-loss-submission-form-2/?id=184880&from=3 CLASS PERIOD: February 25, 202 ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - March 27, 2026) ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - March 26, 2026) ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, encouraging affected investors to contact the firm directly [2][4]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false and misleading statements, including shipping products in excess of need, which inflated revenue [4]. - It is claimed that Zynex's practice of filing false claims attracted scrutiny from insurers, particularly Tricare, which is Zynex's largest customer, accounting for 20-25% of revenue [4][5]. - The lawsuit indicates that Zynex's aggressive sales strategies prioritized order growth over compliance with industry regulations, leading to potential adverse consequences such as removal from insurer networks [4]. Group 2: Financial Impact and Stock Performance - On March 11, 2025, Zynex reported a significant revenue shortfall due to slower payments from payers, with Tricare temporarily suspending payments for claim reviews [5]. - Following this news, Zynex's stock price fell by $3.59 per share, or 51.3%, closing at $3.41 per share on March 12, 2025 [6]. - On July 31, 2025, Zynex acknowledged non-compliance with industry regulations and announced a leadership change, which led to a further decline in stock price from $2.23 to $1.26 per share, a 45% drop [7][8].

ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026 Accessibility Statement Skip NavigationFaruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partne ...

Core Viewpoint - Class actions have been initiated on behalf of stockholders of Lakeland Industries, Inc. and Zynex, Inc., with specific deadlines for investors to petition the court to serve as lead plaintiff [1] Lakeland Industries, Inc. (NASDAQ:LAKE) - Class period for the lawsuit is from December 1, 2023, to December 9, 2025, with a lead plaintiff deadline of April 24, 2026 [4] - Allegations include that Lakeland faced significant issues with its Pacific Helmets and Jolly businesses, such as shipping delays, production issues, and a slower rollout of new products [4] - The lawsuit claims that the defendants overstated the positive impact of these businesses on Lakeland's financial results and the overall strength of operations [4] - Financial results reported for Q3 2026 included net sales of $47.6 million, with adjusted EBITDA at $200,000, a decrease of $4.5 million or 95% compared to the prior year [4] - The company reported a net loss of $16 million or ($1.64) per share, contrasting with a net income of $100,000 or $0.01 per share in the prior-year quarter [4] - Following the earnings report, Lakeland's stock price fell by $5.85 per share, or 38.97%, closing at $9.16 per share on December 10, 2025 [4] Zynex, Inc. (OTCPK:ZYXIQ) - Class period for the lawsuit is from February 25, 2021, to December 15, 2025, with a lead plaintiff deadline of April 21, 2026 [5] - Allegations against Zynex include shipping products in excess of need, inflating revenue, and engaging in a fraudulent overbilling scheme that drew scrutiny from insurers [5] - The lawsuit claims management prioritized aggressive sales strategies over compliance with industry laws, leading to potential adverse consequences, including removal from insurer networks [5] - Defendants' positive statements about Zynex's business and operations are alleged to be materially misleading and lacking a reasonable basis [5]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Zynex To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Zynex between February 25, 2021 and December 15, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile Corp. - March 10, 2026) ...

Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. for alleged securities fraud affecting investors between February 25, 2021, and December 15, 2025 [1] Group 1: Allegations and Company Practices - The lawsuit alleges that Zynex shipped products, including electrodes, in excess of need, inflating its revenue [2] - It is claimed that Zynex's practice of filing false claims drew scrutiny from insurers, including the health insurance program, Tricare [2] - Travelers initiated an action against Zynex and its executives, alleging a fraudulent overbilling scheme and seeking over $23 million in damages related to hundreds of fraudulent claims from 2018 to 2023 [2] - The management prioritized aggressive sales strategies over compliance with industry laws, leading to illegal overbilling practices [2] - The audit committee allegedly acted with reckless disregard for the underlying fraud, helping to bolster the Company's stock price through stock repurchase plans [2] Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the relevant time frame have until April 21, 2026, to request to be appointed as lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky has a track record of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Zynex, Inc. due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a federal class action by April 21, 2026 [2]. Group 1: Allegations Against Zynex - The complaint alleges that Zynex and its executives made false or misleading statements and failed to disclose critical information, including shipping excess products, which inflated revenue [4]. - Zynex's practices drew scrutiny from insurers, particularly Tricare, which is the company's largest customer, accounting for 20-25% of revenue [5][4]. - A lawsuit filed by Travelers against Zynex and its executives claims over $23 million in damages related to fraudulent billing practices from 2018 to 2023 [4]. Group 2: Financial Impact and Stock Performance - On March 11, 2025, Zynex reported a significant revenue shortfall due to slower payments from payers, leading to a stock price drop of $3.59 per share, or 51.3%, closing at $3.41 on March 12, 2025 [5][6]. - Following the acknowledgment of non-compliance with industry regulations on July 31, 2025, Zynex's stock fell from $2.23 to $1.26 per share, a 45% decline [7][8]. Group 3: Legal Proceedings and Investor Actions - Investors who purchased Zynex securities between February 25, 2021, and December 15, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action is open to any member of the putative class, with the ability to direct and oversee the litigation [9].

Core Viewpoint - Zynex, Inc. is facing a class action lawsuit due to allegations of issuing false and misleading statements, resulting in inflated revenue and fraudulent overbilling practices [3][4]. Allegations - The complaint alleges that Zynex shipped products in excess of need, leading to inflated revenue [3]. - The company is accused of filing false claims that drew scrutiny from insurers, including Tricare [3]. - Travelers initiated legal action against Zynex and its executives, seeking over $23 million in damages related to fraudulent claims from 2018 to 2023 [3]. - Management prioritized aggressive sales strategies over compliance with industry regulations [3]. - The company allegedly lacked a commitment to maintaining a strong internal control environment [3]. - Order growth was reportedly a result of illegal overbilling practices [3]. - There is a reasonable likelihood of adverse consequences for Zynex, including removal from insurer networks and federal penalties [3]. - Positive statements made by the defendants regarding the company's business were materially misleading [3]. Legal Proceedings - Shareholders who purchased ZYXIQ shares between February 25, 2021, and December 15, 2025, are encouraged to register for the class action [4]. - The deadline for shareholders to seek lead plaintiff status is April 21, 2026 [4]. - Registered shareholders will receive updates throughout the case lifecycle [4]. Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors affected by misleading statements [5].